Evidence map›Paper›PMID 23799149›Full record

ArticlePloS one2013

Dynamics of physical interaction between HIV-1 Nef and ASK1: identifying the interacting motif(s).

Balawant Kumar, Chakrapani Tripathi, Ranjana K Kanchan, Jitendra Kumar Tripathi, Jimut K Ghosh, Ravishankar Ramachandran, Smrati Bhadauria, Raj Kamal Tripathi

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Balawant KumarDivision of Toxicology, Central Drug Research Institute (Council of Scientific & Industrial Research), BS-10/1, Sector-10 Jankipuram Extension, Uttar Pradesh, India.
Chakrapani Tripathi
Ranjana K Kanchan
Jitendra Kumar Tripathi
Jimut K Ghosh
Ravishankar Ramachandran
Smrati Bhadauria
Raj Kamal Tripathi
Central Drug Research Institute · INCouncil of Scientific and Industrial Research · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

FasL mediated preferential apoptosis of bystander CTLs while protection of infected CD4(+)T cells remains one of the hallmarks of immune evasion during HIV infection. The property of infected host cells to evade cell-autonomous apoptosis emanates from ability of HIV-1Nef-protein to physically interact with ASK-1 and thereby inhibit its enzymatic activity. The specific domains of HIV-1Nef through which it may interact with ASK1 and thereby impair the ASK1 activity remain unidentified so far and represent a major challenge towards developing clear understanding about the dynamics of this interaction. Using mammalian two hybrid screen in association with site directed mutagenesis and competitive inhibitor peptides, we identified constituent minimal essential domain (152 DEVGEANN 159) through which HIV-1Nef interacts with ASK1 and inhibits its function. Furthermore our study also unravels a novel alternate mechanism underlying HIV-1 Nef mediated ASK1 functional modulation, wherein by potentiating the inhibitory ser(967) phosphorylation of ASK1, HIV-1Nef negatively modulated ASK1 function.

Indexed as

Amino Acid SequenceApoptosisBinding, CompetitiveBinding SitesHEK293 CellsHIV-1Host-Pathogen InteractionsHumansJurkat CellsMAP Kinase Kinase Kinase 5nef Gene Products, Human Immunodeficiency VirusPeptide FragmentsProtein BindingProtein Interaction Domains and MotifsTwo-Hybrid System TechniquesMAP3K5 protein, humanMAP Kinase Kinase Kinase 5nef Gene Products, Human Immunodeficiency Virusnef protein, Human immunodeficiency virus 1Peptide Fragments

Identifiers

PMID23799149
PMCPMC3683068
OpenAlexW2084583076

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.